Generate a tailored SOP for Dr. Frank Hernandez. Improve your application with a focused, well-structured draft.
Frank Hernandez is an Associate Professor and Group Leader at the Nucleic Acids Technologies Lab (NAT-Lab) at Linköping University. He obtained his B.Sc. in Microbiology from the University of Antioquia, Colombia, in 2003, followed by a PhD in Bioengineering from the University Rovira i Virgili, Spain, in 2008, where he focused on molecular recognition elements for nucleic acids biosensing. His postdoctoral research at the Nucleic Acid Center of the University of Southern Denmark expanded his expertise in nucleic acid-based technologies. Hernandez then moved to the USA, working at the University of Iowa Carver College of Medicine, where he applied his knowledge to biological problems using cell cultures and animal models. His work has led to advancements in drug delivery systems and the development of novel probes for detecting bacteria in vivo. At Linköping University, Hernandez's research centers on developing diagnostic and therapeutic strategies using nucleic acid probes for cancer and bacterial infections.
Patent regarding oligonucleotide-based probes for detecting bacterial nucleases.
Patent related to methods using nucleic acid aptamers.
Patent on aptamer-gated nanoparticles for lateral flow assays.
Patent for methods of detecting microbes with oligonucleotide probes.
Patent dealing with the detection of nuclease activity.
Requirements are standardized across the Faculty of Science and Engineering (Institute of Technology) for international Master's programs.